Literature DB >> 35622250

LINC00839 Promotes the Progression of Gastric Cancer by Sponging miR-1236-3p.

J X An1, Z S Ma2, W J Yu1, B J Xie1, F S Zhu1, Y X Zhou1, F L Cao3.   

Abstract

In this paper, LINC00839 expression in gastric cancer (GC) was confirmed by real-time quantitative PCR. The function of LINC00839 in GC was detected by loss of function assays. Luciferase assays was performed to confirm the interaction between LINC00839 and miR-1236-3p. Then we investigated the regulatory effect of LINC00839 on miR-1236-3p. The results confirmed that the expression level of LINC00839 in GC was significantly up-regulated. LINC00839 could promote GC cell proliferation, mobility, and invasion. The detection of luciferase reporter gene confirmed that LINC000839 could bind to the binding site of miR-1236-3p. Our findings suggest that LINC00839 promotes GC progression through sponging miR-1236-3p.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  LINC00839; epithelial–mesenchymal transition; gastric cancer; miR-1236-3p; sponging

Mesh:

Substances:

Year:  2022        PMID: 35622250     DOI: 10.1007/s10517-022-05498-z

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  9 in total

Review 1.  Circular RNAs function as ceRNAs to regulate and control human cancer progression.

Authors:  Yaxian Zhong; Yajun Du; Xue Yang; Yongzhen Mo; Chunmei Fan; Fang Xiong; Daixi Ren; Xin Ye; Chunwei Li; Yumin Wang; Fang Wei; Can Guo; Xu Wu; Xiaoling Li; Yong Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2018-04-07       Impact factor: 27.401

2.  LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b.

Authors:  Yingrui Fan; Weiwei Sheng; Yi Meng; Yundi Cao; Rong Li
Journal:  Artif Cells Nanomed Biotechnol       Date:  2020-12       Impact factor: 5.678

3.  LncRNA APPAT regulated miR-328a/Pkp1 signal pathway to participate in breast cancer.

Authors:  W-F Wang; N Zhao; Y-Q Li; M-Y Luo; S-Q Xiao; W Yang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-05       Impact factor: 3.507

4.  Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer.

Authors:  Wei Xu; Gai Zhou; Huizhi Wang; Yawen Liu; Baoding Chen; Wei Chen; Chen Lin; Shuhui Wu; Aihua Gong; Min Xu
Journal:  Int J Cancer       Date:  2019-11-23       Impact factor: 7.396

Review 5.  RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts.

Authors:  Sarah Geisler; Jeff Coller
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-09       Impact factor: 94.444

6.  LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215.

Authors:  Xiaoli Kong; Yi Duan; Yuting Sang; Yaming Li; Hanwen Zhang; Yiran Liang; Ying Liu; Ning Zhang; Qifeng Yang
Journal:  J Cell Physiol       Date:  2018-10-26       Impact factor: 6.384

7.  LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis.

Authors:  Junzheng Chen; Xitian Huang; Weijun Wang; Hongcheng Xie; Jianfeng Li; Zhenfen Hu; Zhijian Zheng; Huiyong Li; Lingfang Teng
Journal:  Aging (Albany NY)       Date:  2018-11-29       Impact factor: 5.682

8.  LncRNA BCAR4 promotes liver cancer progression by upregulating ANAPC11 expression through sponging miR‑1261.

Authors:  Yu Zhang; Hongyan Zhou
Journal:  Int J Mol Med       Date:  2020-04-22       Impact factor: 4.101

9.  miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2.

Authors:  Jia-Xiang An; Ming-Hui Ma; Chun-Dong Zhang; Shuai Shao; Nuo-Ming Zhou; Dong-Qiu Dai
Journal:  Cancer Cell Int       Date:  2018-05-01       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.